摘要 |
The present invention discloses a compound of formula 1, or a pharmaceutically acceptable salt thereof: wherein X<SUP>1 </SUP>represents hydrogen, halogen, C<SUB>1-6 </SUB>alkyl, trifluoromethyl or C<SUB>1-6 </SUB>alkoxy; X<SUP>2 </SUP>represents hydrogen or halogen; Y represents a chemical bond, an oxygen atom, or a -NH- linkage; Z represents an optionally substituted aryl or heteroaryl group; R<SUP>1 </SUP>represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano, trifluoromethyl, nitro, -OR<SUP>a</SUP>, -SR<SUP>a</SUP>, -SOR<SUP>a</SUP>, -SO<SUB>2</SUB>R<SUP>a</SUP>, -SO<SUB>2</SUB>NR<SUP>a</SUP>R<SUP>b</SUP>, NR<SUP>a</SUP>R<SUP>b</SUP>, -NR<SUP>a</SUP>COR<SUP>b</SUP>, -NR<SUP>a</SUP>CO<SUB>2</SUB>R<SUP>b</SUP>, -COR<SUP>a</SUP>, -CO<SUB>2</SUB>R<SUP>a</SUP>, -CONR<SUP>a</SUP>R<SUP>b </SUP>or -CR<SUP>a</SUP>&=NOR<SUP>b</SUP>; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group; a pharmaceutical composition comprising it; its use in a method of treatment; use of it to manufacture a medicament; and a method of using it to prevent or treat anxiety, convulsions or cognitive disorders.
|